Emergency management and asthma risk in young Medicaid-enrolled children with recurrent wheeze

Isabel J Hardee1, Isabella Zaniletti2, Melisa S Tanverdi3

  • 1Department of Pediatrics, University of CO School of Medicine, Children's Hospital Colorado, Aurora, CO, USA.

Insights

Young children with recurrent wheeze who develop persistent wheeze are at risk for childhood asthma. Identifying risk factors like male sex and Black race can aid early asthma detection and prevention.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Epidemiology

Background:

  • Recurrent wheeze in young children is a common reason for emergency department (ED) visits.
  • Identifying children at risk for persistent wheeze and subsequent childhood asthma is crucial for timely intervention.

Purpose of the Study:

  • To describe the clinical characteristics of young children presenting to the ED for early recurrent wheeze.
  • To determine factors associated with subsequent persistent wheeze and the risk for early childhood asthma.

Main Methods:

  • A retrospective cohort study analyzed Medicaid-enrolled children aged 0-3 years with a history of recurrent wheeze.
  • Data from index ED visits and subsequent outcomes up to ages 4-6 years were collected.
  • Logistic regression identified risk factors for persistent wheeze.

Main Results:

  • Over 41,000 children were included; 28% experienced persistent wheeze between ages 4-6.
  • Factors associated with persistent wheeze included male sex, Black race, atopy, and prior use of bronchodilators or corticosteroids.
  • A higher number of wheezing episodes correlated with increased odds of ED asthma medication treatment.

Conclusions:

  • Young children with persistent wheeze face an elevated risk of developing childhood asthma.
  • Early identification of risk factors for persistent wheeze in this population can facilitate earlier asthma diagnosis and preventative strategies.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
403
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
298